BIIB vs DECK · P/E 21, rev $9.89B vs P/E 16, rev $4.99B
Biogen Inc (BIIB) versus Deckers Outdoor Corporation (DECK) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Deckers Outdoor Corporation (DECK) is a footwear & accessories company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported DECK revenue for 2025-03-31 was $4.99B. Net income was $966.1M. Revenue was up 419.5% from 2024-03-31 to 2025-03-31. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. DECK currently screens at market cap $15.23B and trailing P/E 16.1.
Not investment advice. Open the BIIB and DECK stock pages for the full models.
Not investment advice.